{
    "pmcid": "10869273",
    "qa_pairs": {
        "How many variants per antibody were tested in the study to achieve significant improvements in binding affinity?": [
            "20 or fewer",
            "50 or more",
            "100 or more",
            "10 or fewer"
        ],
        "What is one of the broader implications of the study's findings regarding protein engineering?": [
            "General evolutionary rules can guide the selection of beneficial mutations without specific knowledge of protein function or structure.",
            "Specific knowledge of protein structure is essential for selecting beneficial mutations.",
            "Random mutagenesis is the only effective method for protein engineering.",
            "High-throughput screening is necessary for identifying beneficial mutations."
        ],
        "What is the primary focus of the paper 'Efficient evolution of human antibodies from general protein language models'?": [
            "Improving binding affinity of human antibodies using general protein language models.",
            "Developing new protein language models specific to SARS-CoV-2.",
            "Understanding the structure of SARS-CoV-2 spike protein.",
            "Analyzing the genetic sequence of SARS-CoV-2 variants."
        ],
        "Which antibodies targeting the SARS-CoV-2 spike protein were mentioned as being improved in the study?": [
            "S309 and REGN10987",
            "CR3022 and LY-CoV555",
            "B38 and CB6",
            "REGN10933 and LY-CoV016"
        ],
        "Which language models were utilized in the study to guide the evolution of human antibodies?": [
            "ESM-1b and ESM-1v",
            "BERT and GPT-3",
            "AlphaFold and Rosetta",
            "DeepBind and DeepSEA"
        ]
    }
}